会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Method of reducing low density liproprotein cholesterol concentration
    • 降低低密度脂蛋白胆固醇浓度的方法
    • US07285297B1
    • 2007-10-23
    • US10461751
    • 2003-06-13
    • Doyle H. WaggleSusan M. PotterEdna C. Henley
    • Doyle H. WaggleSusan M. PotterEdna C. Henley
    • A01N65/00G01N31/00
    • A61K31/78A23L33/11A23L33/185A23V2002/00A61K36/48Y10T436/104165A61K2300/00A23V2250/5488A23V2250/2116A23V2250/21368A23V2250/70A23V2250/156A23V2250/21372A23V2250/2136
    • The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone.
    • 本发明是一种包含植物甾醇和大豆蛋白材料和/或异黄酮的组合物,其选自染料木黄酮,黄豆苷原,黄豆黄素,鹰嘴豆素A,form e酮及其天然存在的糖苷,其中植物甾醇包含至少0.49% 组成,重量。 本发明还是一种降低人类共同施用植物甾醇和大豆蛋白物质和/或异黄酮的人的总胆固醇和低密度脂蛋白胆固醇的血液浓度的方法,其中植物甾醇至少包含 0.49重量%的植物甾醇和大豆蛋白材料和/或异黄酮的总重量。 本发明还是一种预防或最小化其中植物甾醇和大豆蛋白材料和/或异黄酮共同给予人的动脉粥样硬化发展的方法,其中植物甾醇包含至少0.49% (重量)植物甾醇和大豆蛋白材料和/或异黄酮的总重量。
    • 5. 发明授权
    • Administering a composition containing plant sterol, soy protein and isoflavone for reducing LDL-cholesterol
    • 管理含有植物甾醇,大豆蛋白和异黄酮的组合物,用于降低LDL-胆固醇
    • US06572876B2
    • 2003-06-03
    • US09814649
    • 2001-03-22
    • Doyle H. WaggleSusan M. PotterE. C. Henley
    • Doyle H. WaggleSusan M. PotterE. C. Henley
    • A61K968
    • A61K36/48A23L33/11A23L33/185A23V2002/00A61K31/78A61K2300/00A23V2250/5488A23V2250/2116A23V2250/2136A23V2250/70A23V2250/156A23V2250/21368A23V2250/21372
    • A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. A preferred method involves co-administering to a human a plant sterol and a soy protein material containing at least 0.49% by weight soy protein and containing the isoflavone glycoside, glycitin. The plant sterol is at least 0.49% by combined weight of the co-administered plant sterol and soy protein material. The plant sterol can be B-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol. Also an isoflavone can be administered in combination with the plant sterol and soy protein material. This isoflavone can be genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates.
    • 提供了一种组合物,其包含植物甾醇和大豆蛋白材料和/或异黄酮,所述植物甾醇和/或异黄酮选自染料木黄酮,黄豆苷原,黄豆黄素,鹰嘴豆素A,海参素及其天然存在的糖苷,其中植物甾醇包含至少0.49% 重量。 本发明还是一种减少人类中总共和低密度脂蛋白胆固醇的血液浓度的方法,其中将植物甾醇和大豆蛋白物质和/或异黄酮共同施用于人,其中植物甾醇至少包含 0.49重量%的植物甾醇和大豆蛋白材料和/或异黄酮的总重量。 还提供了一种预防或最小化动物动脉粥样硬化发展的方法,其中植物甾醇和大豆蛋白材料和/或异黄酮共同施用于人,其中植物甾醇包含至少0.49%,通过 重量,植物甾醇和大豆蛋白材料和/或异黄酮的总重量。 优选的方法包括向人类共同施用植物甾醇和含有至少0.49重量%大豆蛋白并含有异黄酮糖苷,大豆蛋白的大豆蛋白物质。 植物甾醇与共同施用的植物甾醇和大豆蛋白材料的组合重量至少为0.49%。 植物甾醇可以是β-谷甾醇,菜油甾醇,豆甾醇,谷甾醇或菜油甾烷醇。 异黄酮也可以与植物甾醇和大豆蛋白材料组合施用。 这种异黄酮可以是染料木素,黄豆苷元,黄豆黄素,鹰嘴豆素A,海参素及其天然存在的糖苷和糖苷共轭物。
    • 8. 发明授权
    • Composition containing soy hypocotyl material and plant sterol for reducing LDL-cholesterol
    • 含有大豆下胚轴的物质和用于降低低密度脂蛋白胆固醇的植物甾醇的成分
    • US06579534B2
    • 2003-06-17
    • US09826346
    • 2001-04-04
    • Doyle H. WaggleSusan M. PotterEdna C. Henley
    • Doyle H. WaggleSusan M. PotterEdna C. Henley
    • A61K968
    • A61K36/48A23L33/11A23L33/185A23V2002/00A61K31/78A61K2300/00A23V2250/5488A23V2250/2116A23V2250/2136A23V2250/70A23V2250/156A23V2250/21368A23V2250/21372
    • A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. A preferred composition contains soy hypocotyl material and at least 0.49% by weight plant sterol. The plant sterol can be B-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.
    • 提供了一种组合物,其包含植物甾醇和大豆蛋白材料和/或异黄酮,所述植物甾醇和/或异黄酮选自染料木黄酮,黄豆苷原,黄豆黄素,鹰嘴豆素A,海参素及其天然存在的糖苷,其中植物甾醇包含至少0.49% 重量。 本发明还是一种减少人类中总共和低密度脂蛋白胆固醇的血液浓度的方法,其中将植物甾醇和大豆蛋白物质和/或异黄酮共同施用于人,其中植物甾醇至少包含 0.49重量%的植物甾醇和大豆蛋白材料和/或异黄酮的总重量。 还提供了一种预防或最小化动物动脉粥样硬化发展的方法,其中植物甾醇和大豆蛋白材料和/或异黄酮共同施用于人,其中植物甾醇包含至少0.49%,通过 重量,植物甾醇和大豆蛋白材料和/或异黄酮的总重量。 优选的组合物包含大豆下胚轴材料和至少0.49重量%的植物甾醇。 植物甾醇可以是β-谷甾醇,菜油甾醇,豆甾醇,谷甾醇或菜油甾烷醇。